טוען...
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm
[Image: see text] We have previously shown that the thermolabile, cavity-creating p53 cancer mutant Y220C can be reactivated by small-molecule stabilizers. In our ongoing efforts to unearth druggable variants of the p53 mutome, we have now analyzed the effects of other cancer-associated mutations at...
שמור ב:
| הוצא לאור ב: | ACS Chem Biol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical
Society
2020
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307883/ https://ncbi.nlm.nih.gov/pubmed/31990523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.9b00748 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|